Mirum Pharmaceuticals, Inc. (MIRM) Financials

MIRM Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 646.6 million 398.0 million
2023-09-30 650.6 million 381.6 million
2023-06-30 443.6 million 365.0 million
2023-03-31 333.5 million 192.4 million

MIRM Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -21.6 million 9.7 million
2023-09-30 -18.2 million 8.4 million
2023-06-30 -17.4 million 8.4 million
2023-03-31 -33.8 million 8.6 million

MIRM Net Income

No data available :(

MIRM Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 286.3 million - 1.7 million
2023-09-30 306.0 million - 2.0 million
2023-06-30 330.0 million 305.6 million 2.2 million
2023-03-31 132.1 million - 2.0 million

MIRM Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 46.7 million
2023-09-30 41.1 million
2023-06-30 38.1 million
2023-03-31 37.7 million

MIRM Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 5.0 million 30.8 million 39.9 million 6.3 million
2023-09-30 - 26.1 million 36.5 million -
2023-06-30 15.1 million 22.0 million 32.9 million -
2023-03-31 41000 23.5 million 30.2 million -

MIRM Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 69.6 million 22.6 million
2023-09-30 47.7 million 10.2 million
2023-06-30 37.5 million 6.8 million
2023-03-31 31.6 million 5.0 million

MIRM

Price: $25.84

52 week price:
22.35
35.56

Earnings Per Share: -4.00 USD

P/E Ratio: -6.72

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 266732

Market Capitalization: 1.2 billion

Links: